J Prev Epidemiol. 2021;6(1): e11. doi: 10.34172/jpe.2021.11

Epidemiology and Prevention

High mobility group box 1 (HMGB1) in COVID-19

Fatemeh Kafi 1 ORCID, Alireza Bolourian 2,3, Zahra Mojtahedi 4 ORCID, Alireza Pouramini 1 * ORCID

Cited by CrossRef: 4

1- Alkazmi L, Al‐kuraishy H, Al‐Gareeb A, Alexiou A, Papadakis M, Saad H, Batiha G. The potential role of scavenger receptor B type I (SR‐BI) in SARS‐CoV‐2 infection. Immunity Inflam & Disease. 2023;11(4) [Crossref]
2- Kermani-Alghoraishi M, Pouramini A, Kafi F, Khosravi A. Coronavirus Disease 2019 (COVID-19) and Severe Pericardial Effusion: From Pathogenesis to Management: A Case Report Based Systematic Review. Current Problems in Cardiology. 2022;47(2):100933 [Crossref]
3- Chowdhury S, Bappy M, Chowdhury S, Chowdhury M, Chowdhury N. COVID-19 Induced Cardiovascular Complications and Recent Therapeutic Advances. EJMED. 2021;3(6):17 [Crossref]
4- Nikdoust F, Pazoki M, Mohammadtaghizadeh M, Aghaali M, Amrovani M. Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease. Cardiovasc Toxicol. 2022;22(3):225 [Crossref]